Japanese
close

F-Term-List

(Not Translated)
4C206 Acyclic and carbocyclic compounds in medicinal compositions
A61K31/00 -31/327
A61K31/00-31/327 AA AA00
TYPES OF INVENTION 		AA01 AA02 AA03 AA04 AA10
. Invention of drugs (with claims) . With testing results of medical applications . Invention of chemical substances (with claims) . Invention of processes of preparing chemical substances (with claims) . Others
BA BA00
HYDROCARBONS, HALOGENATED HYDROCARBONS 		BA01 BA02 BA03 BA04 BA05 BA07 BA08 BA09 BA10
. Hydrocarbons (compounds of C and H only) . . Unsaturated acyclic hydrocarbons . . Including carbocyclic rings . . . Attached to unsaturated carbon chains . . Including aromatic rings . Halogenated hydrocarbons . . Including unsaturated acyclic carbons . . Including carbocyclic rings . . Including aromatic rings
CA CA00
ALCOHOLS, PHENOLS, ETHERS 		CA01 CA02 CA03 CA05 CA07 CA08 CA09 CA10
. Alcohols . . With hydroxyl groups attached to acyclic carbon atoms Image 27) . . . Monovalent alcohols . . . Polyvalent alcohols . . . Seven or more carbon atoms . . . . Carbon chains being unsaturated . . . Having carbocyclic rings . . . . With hydroxyl groups attached to unsaturated carbon chains
CA11 CA12 CA13 CA14 CA16 CA17 CA18 CA19 CA20
. . . Having aromatic rings . . . . Including biphenyl Image 28) . . With hydroxyl groups attached to carbocyclic rings . . . With hydroxyl groups attached to condensed carbocyclic rings . With hydroxyl groups attached to carbon atoms of aromatic rings . . Attached to benzene rings Image 29) Image 30) . . . Aromatic rings being substituted by halogens Image 31) . . . Aromatic rings having two or more hydroxyl groups Image 32) Image 33) . . . Aromatic rings having carbon chains to which hydroxyl groups are bonded Image 34) Image 35)
CA21 CA22 CA23 CA24 CA25 CA26 CA27 CA28
. Ethers, acetals, ketals . . Having one ether bond in the molecule . . . Ethers not including rings . . . Ethers including carbocyclic rings . . . . With ether oxygen atoms attached to carbocyclic rings . . . Ethers including aromatic rings . . . . With ether oxygen atoms attached to aromatic rings . . . . . With ether oxygen attached between two aromatic rings
CA31 CA32 CA33 CA34 CA35 CA37 CA38 CA40
. . Having two or more ether bonds in the molecule . . . Attached to different carbon atoms . . . . Having ether oxygen bonding to aromatic rings . . . . . Same aromatic ring containing two or more ether oxygen atoms Image 37) Image 38) . . . . Polyoxyalkylene compounds . . . Bonding to the same carbon atom; Acetals . . . . With two oxygen atoms attached to the carbon of carbocyclic rings . Peroxides
CB CB00
ALDEHYDES, KETONES, KETENES 		CB01 CB02 CB03 CB05 CB07 CB08 CB09
. Aldehydes . . With aldehyde groups attached to acyclic carbon atoms . . . Attached to unsaturated carbon chains to which carbocyclic rings are bonded. . . . Attached to carbon chains to which aromatic rings are bonded. . . With aldehyde groups attached to carbocyclic rings . . With aldehyde groups attached to aromatic rings . . . Attached to benzene rings
CB11 CB12 CB13 CB14 CB15 CB16 CB18 CB19
. Ketones, ketenes . . With carbonyl groups attached to carbon chains . . . Attached to carbon chains to which carbocyclic rings are bonded . . . Attached to carbon chains to which aromatic rings are bonded . . With carbonyl groups attached to carbocyclic rings . . . Attached to condensed carbocyclic ring types . . With carbonyl groups attached to aromatic rings . . . Attached to benzene rings
CB21 CB23 CB24 CB25 CB27 CB28 CB29
. . Cyclic ketones Image 42) . . . To non-condensed six-membered rings (e.g. cyclohexanones) Image 43) . . . Carbonyl carbon atoms being included in condensed rings Image 44) Image 45) . . . With unsaturated carbon chains attached to carbocyclic rings of cyclic ketones Image 46) . . . Quinones . . . . Condensed with rings . . . . . Anthraquinones
DA DA00
CARBOXYLIC ACIDS, THE SALTS, HALIDES, ANHYDRIDES 		DA01 DA02 DA03 DA04 DA05 DA07 DA09
. Monocarboxylic acids not containing rings . . Consecutive carbon atoms being six or less; Lower fatty acids . . Consecutive carbon atoms being seven or more; Higher fatty acids . . . Having one or two C = C bonds . . . Having three or more C = C bonds . . . With single bond oxygen atoms attached to carbon chains . . . Including carbonyl groups in carbon chains
DA11 DA12 DA13 DA14 DA16 DA17 DA18 DA19
. Monocarboxylic acids including carbocyclic rings . . Unsaturated carboxylic acid to which carbocyclic rings are bonded . . With carboxyl groups attached to carbocyclic rings . . . Glycyrrhetinic acids . . Monocarboxylic acids including aromatic rings . . . With carboxyl groups directly attached to aromatic rings . . . . With oxygen atoms further attached to aromatic rings . . . . . With oxygen atoms attached to position 2 of benzene rings
DA21 DA22 DA23 DA24 DA25 DA26 DA28 DA29 DA30
. . . With carboxyl groups attached through carbon chains . . . . With carboxyl groups attached through carbon atoms . . . . . Phenylacetic acid derivatives . . . . . . Ibuprofens . . . . . . Ketoprofens . . . . . . Halogens substituting to aromatic rings . . . Aromatic oxyalkane acids . . . . Aromatic oxyacetic acid derivatives . . . . . Phenoxyacetic acid derivatives
DA34 DA35 DA36 DA37 DA39 DA40
. Polycarboxylic acids . . Dicarboxylic acids . . . Dicarboxylic acid not containing rings . . . Aromatic dicarboxylic acids . Peroxy carboxylic acids . Compounds including other oxygen atoms
DB DB00
ESTERS OF CARBONIC ACIDS, CARBOXYLIC ACIDS 		DB01 DB02 DB03 DB04 DB06 DB07 DB09
. Esters of monocarboxylic acids . . Of carboxylic acids not containing rings . . . Of carboxylic acids having six or less consecutive carbon atoms . . . . Esters with acetic acids . . . Of carboxylic acids having seven or more consecutive carbon atoms . . . . Of acids with one or two C = C bonds . . . . Of acids with three or more C = C bonds
DB11 DB13 DB15 DB16 DB17 DB18 DB20
. . Esters of carboxylic acids including carbocyclic rings . . Esters of carboxylic acid including aromatic rings . . . Of acids of carboxyl groups attached to aromatic rings . . . . Esters of benzoic acids . . . . Of acids of oxygen atoms further attached to aromatic rings . . . . . Of acids of oxygen atoms attached in position 2 . . . Acids to which carboxyl groups are attached through carbon chains
DB21 DB22 DB24 DB25 DB27 DB28 DB29 DB30
. . . . With carboxyl groups attached through carbon atoms . . . . . Of phenylacetic acid derivatives . . . Of aromatic oxyalkane acids . . . . Of phenoxyacetic acid derivatives . Esters of polycarboxylic acids . . Esters of dicarboxylic acids . . . Of acyclic dicarboxylic acids . . . Of aromatic dicarboxylic acids
DB31 DB33 DB35
. Esters of peroxy carboxylic acids . Esters of carbonic acids . Esters of oxyacids of halogens
DB41 DB42 DB43 DB44 DB45 DB46 DB47 DB48 DB49 DB50
. Esters of unspecified alcohols . With ester oxygen attached to carbon chains . . Esters of monovalent alcohols . . Of polyvalent alcohols . . . Of divalent alcohols; Of glycols . . . Of trivalent alcohols . . . . Of glycerols . . . . . Triglycerides . . Of alcolohs having seven or more carbon atoms . . . Of unsaturated alcohols
DB51 DB52 DB53 DB54 DB56 DB57 DB58
. . Of alcohols of carbocyclic rings attached to carbon chains . . . Of alcohols of condensation carbocyclic rings attached to carbon chains . . Of alcohols of aromatic rings attached to carbon chains . . . Of alcohols of benzene rings attached to carbon chains . With ester oxygen attached to carbocyclic rings . With ester oxygen attached to aromatic rings . . Of polyphenols
EA EA00
NITRO, NITROSO; NITRATES, NITRITES 		EA01 EA02 EA03 EA04 EA06 EA07
. Compounds including nitro, nitroso groups . . Attached to aromatic rings . . . With oxygen atoms attached to aromatic rings . . . With carboxyl groups attached to aromatic rings . Nitrates, nitrites . . Nitroglycerines
FA FA00
AMINES 		FA01 FA02 FA03 FA05 FA07 FA08 FA09 FA10
. With nitrogen atoms attached to acyclic carbon atoms . . With single bond oxygen atoms attached to carbon chains of amines . . . 2-Ethanolamines, the derivatives . . . . Etherified with carbon chains including aromatic rings . . With aromatic rings attached to carbon chains . . . Attached with benzene rings that may be substituted . . . . To carbon chains to which unsubstituted benzene rings are attached . . . . . With single bond oxygen atoms attached to carbon chains
FA11 FA12 FA13 FA14 FA15 FA17 FA18 FA19
. . . . Carbon chains to which oxygen bonding benzene rings are attached . . . . . Dopamines . . . . . Dobutamines . . . . . With single bond oxygen atoms attached to carbon chains . . . . . . Isoproterenols . . With aromatic oxy groups attached to carbon chains . . . Attached with condensed aromatic ring oxy groups . . . . Propranolols
FA21 FA22 FA23 FA25 FA27 FA29
. . . Attached with phenoxy group that may be substituted . . . . Attached with carbon chains to which aromatic rings are attached . . . . . Attached with carbon atoms to which aromatic rings are attached . . . . Phenoxy groups to which oxygen atoms are attached . . Nitrogen atom bond carbon skeletons containing double bond oxygen atoms . With nitrogen atoms attached to carbocyclic rings
FA31 FA32 FA33 FA35 FA36 FA37 FA38 FA40
. With nitrogen atoms attached to aromatic rings . . With carboxyl groups attached to aromatic rings . . . Ortho-aminobenzoic acids; derivatives thereof . . . Para-aminobenzoic acids; derivatives thereof . . . . Carboxyl groups being esterified . . . . . Esterification with carbon chains having amino groups . . . . . . Procaines . . . . Aromatic rings being substituted by oxygen atoms
FA41 FA42 FA44 FA45 FA47
. Quaternary ammonium compounds . . Containing nitrogen attached to carbon skeletons bonding with oxygen . With amino groups and CO2R groups attached to the same carbon chains . . Gamma-aminobutyric acids; GABA . . With oxygen atoms attached to carbon chains
FA51 FA53 FA55 FA56 FA58 FA59
. . With amino groups and CO2R groups attached to the same carbon atom . . . Alpha amino acids; esters thereof . . . EDTA . . . DOPA, methyl DOPA . . Betaines . . . Carnitines; derivatives thereof
GA GA00
AMIDES OF CARBOXYLIC ACIDS 		GA01 GA02 GA03 GA04 GA05 GA06 GA07 GA08 GA09
. Amides of monocarboxylic acids not containing rings . . Amides of acetic acids . . Of carboxylic acids of seven or more consecutive carbon atoms . . Of acids for which carbon chains are substituted by single bond oxygen . . . Of pantoic acids . Amides of monocarboxylic acids including carbocyclic rings . Amides of monocarboxylic acids including aromatic rings . . Unsubstituted . . Amides of aromatic acetic acid derivatives
GA11 GA12 GA13 GA14 GA16 GA17 GA18 GA19 GA20
. Amides of polycarboxylic acids . . Of dicarboxylic acids . . . Of acyclic dicarboxylic acids . . . Of aromatic dicarboxylic acids . Of carboxylic acids containing amino groups in the same carbon skeleton . . Carboxamides of amino benzoic acid derivatives . Of carboxylic acids containing amino groups in the same carbon chain . . Carboxamides of alpha amino acids . . . Asparagines or glutamines
GA21 GA22 GA23 GA25 GA26 GA28 GA30
. Amides of unspecified amines . Of NH2 or unsubstituted alkylamines . With nitrogen of amides attached to carbon chains Image 64), GA22 takes precedence . . Of amines with oxygen atoms attached to carbon chains . . . 2-Ethanolamines; derivatives thereof . . Of amines with aromatic rings attached to carbon chains . Of amines with amino groups attached to carbocyclic rings
GA31 GA32 GA33 GA34 GA36 GA37
. Of amines with amino groups attached to aromatic rings . . Of amines of aromatic rings having carboxyl groups . . . Of amino groups of ortho-position of carboxyl groups . . . Of amino groups of para-position of carboxyl groups . Of amines with COOR groups attached to the same carbon chain . . Of amino groups of alpha amino acids
HA HA00
COMPOUNDS INCLUDING OTHER FUNCTIONAL GROUPS CONTAINING NITROGEN 		HA01 HA03 HA05 HA07 HA08 HA09 HA10
. Hydroxy amino compounds, ethers thereof . Compounds including N-N groups; N-Nitroso compounds . Compounds including N=N multiple bonds . Compounds including imino groups Image 69) . . Oximes, hydrazones, azines Image 70) . . Imino ethers, imino halides Image 71) . . Amidines (- C(=N-N) Image 72)
HA11 HA12 HA13 HA14 HA16 HA18 HA20
. Nitriles, isonitriles (-CN, -NC) . . Attached to carbon chains . . . With attached to carbon chains to which aromatic rings are attached . . Attached to aromatic rings . Hydroxamic acids, N-hydroxyamidines Image 73) . Cyanates, isocyanates Image 74) . Carbodiimides (-N=C=N-) Image 75)
HA21 HA22 HA23 HA24 HA26 HA27 HA28 HA29 HA30
. Carbamic acids, derivatives thereof . . With oxygen atoms attached to carbon chains Image 79) . . . With oxygen atoms attached to carbon chains including aromatic rings Image 80) . . With oxygen atoms attached to aromatic rings . Derivatives of urea (-N-C(=O)-N-) . . Unsubstituted ureas Image 84) . . With nitrogen atoms attached to carbon chains Image 85) . . . Nitrogen atoms to carbon chains containing aromatic rings Image 86) . . With nitrogen atoms attached to aromatic rings Image 87)
HA31 HA32 HA40
. Derivative of guanidines . . Arginines, creatines . Others
JA JA00
COMPOUNDS CONTAINING SULFUR, SELENIUM, TELLURIUM 		JA01 JA02 JA04 JA06 JA08 JA09
. Compounds containing sulfur . . Esters, amides of sulfuric acids or sulfurous acids . . Sulfonic acids, derivatives thereof . . . With sulfur atoms of acids attached to carbon chains Image 93) . . . . Carbon chains being substituted by nitrogen Image 94) . . . With sulfur atoms of sulfonic acids attached to aromatic rings Image 95)
JA11 JA13 JA14 JA15 JA16 JA17 JA18 JA19 JA20
. . Amides of sulfonic acids . . . With sulfur atoms of sulfonic acids attached to aromatic rings . . . . Of sulfonic acids of aromatic rings with amino groups . . . . . Of 4-aminobenzenesulfonic acids . . . . . . With nitrogen atoms of sulfonamides attached to aromatic rings . . Sulfonylurea derivatives . . Sulfenic acids, sulfinic acids . . Sulfones, sulfoxides . . . Between two aromatic rings
JA21 JA22 JA23 JA24 JA25 JA26 JA27 JA28 JA30
. . Sulfides (-S-) . . . With sulfur atoms attached to carbon chains Image 97) . . . . With attached to carbon chains having carboxyl groups Image 98) . . . . With attached to carbon chains having carbonamide groups Image 99) . . . . With attached to carbon chains having amino groups Image 100) . . . . To carbon chains having amino groups and carboxyl groups Image 101) . . . . . Methionines . . . . . Amide derivatives of methionines . . . . With sulfur atoms attached to carbon chains to which aromatic rings are attached Image 103)
JA31 JA32 JA34 JA35 JA36 JA37 JA39 JA40
. . . With sulfur atoms attached to carbocyclic rings . . . With sulfur atoms attached to aromatic ring . . . . Further with attached to carboxyl group bond carbon chains Image 104) . . . . Carboxyl groups being formed to amides Image 105) . . . . Further with attached to amino group bond carbon chains Image 106) . . . . Amino groups being acylated Image 107) . . . . With carboxyl group containing carbon chains attached to aromatic rings Image 108) . . . . The carboxyl groups being formed to amides Image 109)
JA41 JA42 JA43 JA44 JA45 JA46 JA47 JA49
. . . . With amino groups containing carbon chains attached to aromatic rings Image 110) . . . . Amino groups being acylated Image 111) . . . . With carboxyl groups attached to aromatic rings . . . . Carboxyl groups being formed to amides . . . . With amino groups attached to aromatic rings . . . . Amino groups being acylated Image 112) . . . . S atoms to amino groups and CO2R group bonding aromatic rings Image 113) . . . . Sulfur atoms being between two aromatic rings
JA51 JA52 JA53 JA54 JA55 JA57 JA58 JA59 JA60
. . Thiols (-SH) . . . With sulfur atoms attached to carbon chains Image 114) . . . . With sulfur atoms attached to carbon chains having aromatic rings Image 115) . . . With sulfur atoms attached to carbocyclic rings . . . With sulfur atoms attached to aromatic rings . . . S atoms to amino groups and CO2R group bonding aromatic rings Image 116) . . . . Cysteines . . . . Amide derivatives of cysteines . . . . Pantetheines
JA61 JA62 JA63 JA65 JA66 JA68 JA70
. . Hydropolysulfides, polysulfides . . . Cystines . . . Pantethines . . Thioaldehydes, thioketones, S-oxides thereof . . Thiocarboxylic acids; derivatives thereof . . Derivatives of thiocarbonic acids . . Thiocyanates, thioisocyanates Image 124)
JA71 JA72 JA74 JA76 JA78 JA79 JA80
. . Thiocarbamic acids; derivatives thereof . . . Thiuram derivatives . . Thioureas, isothioureas; derivatives thereof . . Compounds including other functional groups containing sulfur and nitrogen . . Thiosulfates, thiosulfonic acids, derivatives thereof . . Sulfonium compounds . Compounds containing selenium or tellurium
JB JB00
ORGANIC COMPOUNDS CONTAINING HEAVY METALS 		JB01 JB02 JB03 JB04 JB05 JB06 JB07 JB08
. Compounds containing either Cu, Ag or Au . Compounds containing Zn . Compounds containing Hg . Compounds containing Sn . Compounds containing Ge . Compounds containing As . Compounds containing Sb . Compounds containing Bi
JB11 JB13 JB14 JB15 JB16 JB17 JB20
. Compounds containing iron groups (Fe, Co, Ni) . Compounds containing platinum groups . . compounds containing platinum . . . Containing four-coordination platinum complexes . . . . Complex having coordinated two amino groups . . . . . Complex having coordinated two chlorine atoms . Organic compounds containing other heavy metals (*)
KA KA00
CHARACTERISTICS OF CHEMICAL STRUCTURES OF ACTIVE INGREDIENTS 		KA01 KA03 KA04 KA05 KA06 KA08 KA09
. Containing carbocyclic rings or aromatic rings . . Containing condensed ring systems . . . Ortho-condensation systems . . . . Three rings containing ortho-condensation ring systems . . . . . Amino groups directly and indirectly bonding to the center ring of three rings Image 138) . . . Crosslinked ring systems . . . . Containing adamantane rings
KA11 KA12 KA13 KA14 KA15 KA16 KA17 KA18 KA19 KA20
. Specific salts or addition products . . With inorganic bases . . With organic bases . . With inorganic acids . . With organic acids (sulfonic acids, carboxylic acids) . Specific crystal systems . Optical isomers . Being derived from natural products (*) . . Being derived from microorganism products . Other characteristics (*)
MA MA00
COMPOUNDING AGENTS, DOSAGE FORMS, APPLICATION SITES 		MA01 MA02 MA03 MA04 MA05 MA06 MA10
. Compounding ingredients described in the scope of claims being one ingredient . Compounding ingredients described in the scope of claims being two ingredients . Ingredients described in the scope of claims being three or more ingredients . Compounding ingredients described in the scope of claims being only efficacious ingredients . Compounding ingredients described in the scope of claims being efficacious ingredients and inactive ingredients . Ingredients described in the scope of claims being known whether efficacious ingredients or inactive ingredients . Amino acid compounding agents
MA11 MA12 MA13 MA14 MA16 MA17 MA18 MA20
. Compound ingredients other than BA-KA . . Heterocyclic compounds . . . Monocyclic and heterocyclic compounds of O and/or S only . . . Other monocyclic type heterocyclic compounds . . . Condensed heterocyclics compounds not containing nitrogen . . . Condensed heterocyclics compounds containing nitrogen . . . . Beta lactam type compound Image 148) . . Prostaglandin type compounds
MA21 MA22 MA23 MA24 MA25 MA26 MA28 MA29 MA30
. . Steroid compounds . . Secosteroids, vitamin Ds . . Tetracycline type compounds . . Compounds containing phosphorus . . Compounds containing boron . . Compounds containing silicon . . Carbohydrates, glycocides, nucleotides, polysaccharides . . Synthetic polymers . . Drugs containing inorganic active ingredients
MA31 MA32 MA33 MA36 MA37
. Dosage forms . . Gaseous . . . Aerosols, foaming agents . . Liquid . . . Solution agents (aqueous solutions, nonaqueous solutions)
MA41 MA42 MA43 MA44 MA47 MA48
. . . Dispersion agents . . . . Emulsions, emulsifying agents . . . . Syrups, suspending agents . . . . Liposomes . . Semisolid shapes . . . Creams, pastes, ointments
MA51 MA52 MA54 MA55 MA56 MA57 MA58
. . . Suppositories, bougies . . . Pasting agents . . Solid shapes . . . Tablets, buccal tablets . . . Pellets . . . Capsules . . . . Microcapsules
MA61 MA63 MA64 MA67
. . . Granular agents . . . Powdered drugs . . . . Freeze-dried powders . . . Gums
MA71 MA72 MA75 MA76 MA77 MA78 MA79 MA80
. Application sites . . Oral . . Parenteral . . . Body cavities, mucosae . . . . Oral cavities . . . . Eyes . . . . Nasal cavities . . . . Recta
MA83 MA85 MA86 MA87 MA90
. . . Transdermal, skin external application . . . Blood vessels, in-tissues . . . . Injection, infusion, instillation . . . . Implantation . Others (*)
NA NA00
PURPOSE AND EFFECTS OF COMPOUNDS PER SE, OR COMPOUNDING AND PREPARATION 		NA01 NA02 NA03 NA04 NA05 NA06 NA07 NA08 NA09 NA10
. Virus inactivation . Solubilization . Stabilization . Time of use preparations . Strengthening of action or improvement of selectivity . Reduction of side action . Decrease of toxicity . Pain relieving . Corrigent, corrective . Change in dosage forms
NA11 NA12 NA13 NA14 NA15 NA20
. Absorbability improvement . Gradual releasing, continuation . Internal drug transportation (DDS) . Expression of new efficacies of drugs . Prodrugs . Others (*)
ZA ZA00
ORGANS OF MEDICAL APPLICATIONS 		ZA01 ZA02 ZA03 ZA04 ZA05 ZA06 ZA07 ZA08
. Drugs acting on nervous systems . . Medicines for the central nervous system . . . Central nervous system suppressants . . . . General anesthetics . . . . Hypnotics, sedatives . . . . Antiepileptics . . . . Antipyretics . . . . Analgesics
ZA11 ZA12 ZA14 ZA15 ZA16 ZA18 ZA20
. . . Central nervous system psychostimulants . . . . Anti-depressants . . . Vertigo sedatives . . . Nootropic agents . . . . Drugs for treating Alzheimer's disease . . . Anti-psychoneural agents . . Medicines for the peripheral nervous system
ZA21 ZA22 ZA23 ZA24 ZA25 ZA26 ZA27 ZA28 ZA29 ZA30
. . . Sensory nerve agents . . . Kinesioneurosis agents . . . . Skeletal muscle relaxants . . . Autonomic nervous agents . . . . Sympathetic nerve stimulants . . . . Sympathetic nerve suppressants . . . . Parasympathomimetic stimulants . . . . Parasympathomimetic suppressants . . . . Antispasmodics . . . . Sudorifics, antiperspirants
ZA31 ZA32 ZA33 ZA34 ZA36 ZA37 ZA38 ZA39 ZA40
. Drugs acting on individual organ . . Medicines for sensory organs . . . Ophthalmic agents . . . Otological agents . . Medicines for circulatory organs . . . Cardiac muscle stimulants . . . Cardiac muscle suppressants . . . Vasodilators . . . . Coronary vasodilators
ZA41 ZA42 ZA43 ZA44 ZA45
. . . Blood vessel contracting agents . . . Hypotensors . . . Blood pressure elevating agents . . . Blood vessel reinforcement agents . . . Antiarteriosclerotic agents
ZA51 ZA52 ZA53 ZA54 ZA55 ZA59 ZA60
. . Medicines for hemocytopoietic organs (marrows), blood, body fluids . . . Blood substitutes . . . Anastaltics and blood coagulants . . . Anti-blood coagulants and thrombolytic agents . . . Antianemics . . Medicines for respiratory organs . . . Respiratory promoters
ZA61 ZA62 ZA63 ZA66 ZA67 ZA68 ZA69 ZA70
. . . Bronchodilators . . . Antibechics . . . Expectorants . . Medicines for digestive organs . . . Dental oral agents . . . Digestive ulceration agents . . . Gastric digestives . . . Anti-obesitas agents
ZA71 ZA72 ZA73 ZA75 ZA76 ZA77
. . . Antiemetics, evacuants . . . Purgatives . . . Agents for intestinal disorders . . . Agents for liver, bile duct systems . . . . Cholagogues . . . . Gallstone dissolving agents
ZA81 ZA82 ZA83 ZA84 ZA85 ZA86 ZA89 ZA90
. . Medicines for urinogenital organs and anals . . . Urinary tract bactericides . . . Diuretics . . . Antidiuretics . . . Uterotonics . . . Contraceptives . . Dermatological agents . . . Dermatological antimicrobial agents
ZA91 ZA92 ZA94 ZA96 ZA97
. . . Skin softening agents . . . Agents for scalps, hairs . . Medicines for musculars . . Medicines for skeletals . . . Osteoporosis agents
ZB ZB00
MEDICAL APPLICATIONS AND BIOLOGICAL DEFENSES 		ZB01 ZB02 ZB03 ZB05 ZB07 ZB08 ZB09
. Drugs specified by action on biophylactic mechanisms . . Medicines for cellular immunomechanisms . . . Interferon derivatives . . Medicines for humoral immunity (antibody production) mechanisms . . Medicines for immunity regulation . . Medicines for immunosuppression . . Medicines for immunity promotion
ZB11 ZB13 ZB15
. . Inflammation agents . . Medicines for allergies . . Medicines for rheumatism
ZB21 ZB22 ZB26 ZB27
. Drugs acting on functions of tissue cells . . Medicines for cell activation . . Medicines for tumors . . . Antileukocytic agents
ZB31 ZB32 ZB33 ZB35 ZB37 ZB38 ZB39
. Drugs acting on pathogenic organisms . . Medicines for pathogenic microbes . . . Antiviral agents . . . Antibacterial agents . . Medicines for parasites . . . Antiprotozoal agents . . . Parasiticides
ZC ZC00
MEDICAL USES, FUNCTIONS, PROCESSES, OBJECTS, AND OTHERS 		ZC01 ZC02 ZC03 ZC04 ZC06 ZC08 ZC10
. Drugs specified by action on vital functions . . In vivo biologically active agent-like medicines . . . Hormone-like drugs . . . . Hypophysis hormone-like agents . . . . Thyroid gland, parathyroid hormone-like agents . . . . Adrenal hormone-like agents . . . . Male hormone-like agents
ZC11 ZC12 ZC13 ZC14 ZC16 ZC17 ZC18 ZC19 ZC20
. . . . Female hormone-like agents . . . Prostaglandin-like agents . . . Anti-histamine-like agents . . . Anti-serotonin-like agents . . . Bradykinin-like agents . . . Angiotensin-llike agents . . . Leukotriene-like agents . . . Enzyme activity and activators . . . Enzyme inhibition agents
ZC21 ZC22 ZC23 ZC24 ZC25 ZC26 ZC28 ZC29
. . Medicines for metabolic systems . . . Vitamin-like agents . . . . Vitamin A, D-like agents . . . . Vitamin B-like agents . . . . . Vitamin B1-like agents . . . . . Vitamin B2-like agents . . . . Vitamin C, P-like agents . . . . Vitamin E, K-like agents
ZC31 ZC33 ZC35 ZC37 ZC39
. . . Uric acid metabolic agents . . . Lipid metabolic agents . . . Glucide metabolic agents . . . Detoxification agents . . . Anti-habitual intoxication agents
ZC41 ZC42 ZC43 ZC44 ZC45 ZC48 ZC50
. Drugs specified by processes . . Medicines for receptor antagonisms (*) . . . Beta-blockers . . . Histamine H2 blockers . . . Histamine H1 blockers . . Medicines for anti-PAF (platelet activating factor) . . Medicines for calcium antagonists
ZC51 ZC52 ZC54 ZC55
. Drugs specified by medical treatment targets . . Medicines for geriatric disease . . Medicines specified by symptoms and names of diseases (*) . . . Agents for AIDS (acquired immunodeficiency syndromes)
ZC61 ZC62 ZC63 ZC64 ZC65
. . Medicines for animals . . . Anti-animal mastitis agents . . . Animal lactagogues . . . Animal coccidiostats . . . Poikilothermic animal agents
ZC71 ZC72 ZC75 ZC78 ZC80
. Drugs relating physiotherapy . . Medicines for moxa cautery therapy . Drugs having synergistic action . Analysis and detection reagent, or the like . Others, unknown (*)
TOP